AI is a viable alternative to high throughput screening: a 318-target study
High throughput screening (HTS) is routinely used to identify bioactive small molecules. This requires physical compounds, which limits coverage of accessible chemical space. Computational approaches combined with vast on-demand chemical libraries can access far greater chemical space, provided that...
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Journal Article |
Language: | English |
Published: |
2024
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/179577 |
_version_ | 1824456209336369152 |
---|---|
author | Wallach, Izhar Bernard, Denzil Nguyen, Kong Ho, Gregory Morrison, Adrian Stecula, Adrian Rosnik, Andreana O’Sullivan, Ann Marie Davtyan, Aram Samudio, Ben Thomas, Bill Worley, Brad Butler, Brittany Laggner, Christian Thayer, Desiree Moharreri, Ehsan Friedland, Greg Truong, Ha van den Bedem, Henry Ng, Ho Leung Stafford, Kate Sarangapani, Krishna Giesler, Kyle Ngo, Lien Mysinger, Michael Ahmed, Mostafa Anthis, Nicholas J. Henriksen, Niel Gniewek, Pawel Eckert, Sam de Oliveira, Saulo Suterwala, Shabbir PrasadPrasad, Srimukh Veccham Krishna Shek, Stefani Contreras, Stephanie Hare, Stephanie Palazzo, Teresa O’Brien, Terrence E. Van Grack, Tessa Williams, Tiffany Chern, Ting-Rong Kenyon, Victor Lee, Andreia H. Cann, Andrew B. Bergman, Bastiaan Anderson, Brandon M. Cox, Bryan D. Warrington, Jeffrey M. Sorenson, Jon M. Goldenberg, Joshua M. Young, Matthew A. DeHaan, Nicholas Pemberton, Ryan P. Schroedl, Stefan Abramyan, Tigran M. Gupta, Tushita Mysore, Venkatesh Presser, Adam G. Ferrando, Adolfo A. Andricopulo, Adriano D. Ghosh, Agnidipta Ayachi, Aicha Gharbi Mushtaq, Aisha Shaqra, Ala M. Toh, Alan Kie Leong Smrcka, Alan V. Ciccia, Alberto de Oliveira, Aldo Sena Sverzhinsky, Aleksandr de Sousa, Alessandra Mara Agoulnik, Alexander I. Kushnir, Alexander Freiberg, Alexander N. Statsyuk, Alexander V. Gingras, Alexandre R. Degterev, Alexei Tomilov, Alexey Vrielink, Alice Garaeva, Alisa A. Bryant-Friedrich, Amanda Caflisch, Amedeo Patel, Amit K. Rangarajan, Amith Vikram Matheeussen, An Battistoni, Andrea Caporali, Andrea Chini, Andrea Ilari, Andrea Mattevi, Andrea Foote, Andrea Talbot Trabocchi, Andrea Stahl, Andreas Herr, Andrew B. Berti, Andrew Freywald, Andrew Reidenbach, Andrew G. Lam, Andrew Cuddihy, Andrew R. White, Andrew Taglialatela, Angelo |
author2 | School of Biological Sciences |
author_facet | School of Biological Sciences Wallach, Izhar Bernard, Denzil Nguyen, Kong Ho, Gregory Morrison, Adrian Stecula, Adrian Rosnik, Andreana O’Sullivan, Ann Marie Davtyan, Aram Samudio, Ben Thomas, Bill Worley, Brad Butler, Brittany Laggner, Christian Thayer, Desiree Moharreri, Ehsan Friedland, Greg Truong, Ha van den Bedem, Henry Ng, Ho Leung Stafford, Kate Sarangapani, Krishna Giesler, Kyle Ngo, Lien Mysinger, Michael Ahmed, Mostafa Anthis, Nicholas J. Henriksen, Niel Gniewek, Pawel Eckert, Sam de Oliveira, Saulo Suterwala, Shabbir PrasadPrasad, Srimukh Veccham Krishna Shek, Stefani Contreras, Stephanie Hare, Stephanie Palazzo, Teresa O’Brien, Terrence E. Van Grack, Tessa Williams, Tiffany Chern, Ting-Rong Kenyon, Victor Lee, Andreia H. Cann, Andrew B. Bergman, Bastiaan Anderson, Brandon M. Cox, Bryan D. Warrington, Jeffrey M. Sorenson, Jon M. Goldenberg, Joshua M. Young, Matthew A. DeHaan, Nicholas Pemberton, Ryan P. Schroedl, Stefan Abramyan, Tigran M. Gupta, Tushita Mysore, Venkatesh Presser, Adam G. Ferrando, Adolfo A. Andricopulo, Adriano D. Ghosh, Agnidipta Ayachi, Aicha Gharbi Mushtaq, Aisha Shaqra, Ala M. Toh, Alan Kie Leong Smrcka, Alan V. Ciccia, Alberto de Oliveira, Aldo Sena Sverzhinsky, Aleksandr de Sousa, Alessandra Mara Agoulnik, Alexander I. Kushnir, Alexander Freiberg, Alexander N. Statsyuk, Alexander V. Gingras, Alexandre R. Degterev, Alexei Tomilov, Alexey Vrielink, Alice Garaeva, Alisa A. Bryant-Friedrich, Amanda Caflisch, Amedeo Patel, Amit K. Rangarajan, Amith Vikram Matheeussen, An Battistoni, Andrea Caporali, Andrea Chini, Andrea Ilari, Andrea Mattevi, Andrea Foote, Andrea Talbot Trabocchi, Andrea Stahl, Andreas Herr, Andrew B. Berti, Andrew Freywald, Andrew Reidenbach, Andrew G. Lam, Andrew Cuddihy, Andrew R. White, Andrew Taglialatela, Angelo |
author_sort | Wallach, Izhar |
collection | NTU |
description | High throughput screening (HTS) is routinely used to identify bioactive small molecules. This requires physical compounds, which limits coverage of accessible chemical space. Computational approaches combined with vast on-demand chemical libraries can access far greater chemical space, provided that the predictive accuracy is sufficient to identify useful molecules. Through the largest and most diverse virtual HTS campaign reported to date, comprising 318 individual projects, we demonstrate that our AtomNet® convolutional neural network successfully finds novel hits across every major therapeutic area and protein class. We address historical limitations of computational screening by demonstrating success for target proteins without known binders, high-quality X-ray crystal structures, or manual cherry-picking of compounds. We show that the molecules selected by the AtomNet® model are novel drug-like scaffolds rather than minor modifications to known bioactive compounds. Our empirical results suggest that computational methods can substantially replace HTS as the first step of small-molecule drug discovery. |
first_indexed | 2025-02-19T03:50:28Z |
format | Journal Article |
id | ntu-10356/179577 |
institution | Nanyang Technological University |
language | English |
last_indexed | 2025-02-19T03:50:28Z |
publishDate | 2024 |
record_format | dspace |
spelling | ntu-10356/1795772024-08-12T15:31:59Z AI is a viable alternative to high throughput screening: a 318-target study Wallach, Izhar Bernard, Denzil Nguyen, Kong Ho, Gregory Morrison, Adrian Stecula, Adrian Rosnik, Andreana O’Sullivan, Ann Marie Davtyan, Aram Samudio, Ben Thomas, Bill Worley, Brad Butler, Brittany Laggner, Christian Thayer, Desiree Moharreri, Ehsan Friedland, Greg Truong, Ha van den Bedem, Henry Ng, Ho Leung Stafford, Kate Sarangapani, Krishna Giesler, Kyle Ngo, Lien Mysinger, Michael Ahmed, Mostafa Anthis, Nicholas J. Henriksen, Niel Gniewek, Pawel Eckert, Sam de Oliveira, Saulo Suterwala, Shabbir PrasadPrasad, Srimukh Veccham Krishna Shek, Stefani Contreras, Stephanie Hare, Stephanie Palazzo, Teresa O’Brien, Terrence E. Van Grack, Tessa Williams, Tiffany Chern, Ting-Rong Kenyon, Victor Lee, Andreia H. Cann, Andrew B. Bergman, Bastiaan Anderson, Brandon M. Cox, Bryan D. Warrington, Jeffrey M. Sorenson, Jon M. Goldenberg, Joshua M. Young, Matthew A. DeHaan, Nicholas Pemberton, Ryan P. Schroedl, Stefan Abramyan, Tigran M. Gupta, Tushita Mysore, Venkatesh Presser, Adam G. Ferrando, Adolfo A. Andricopulo, Adriano D. Ghosh, Agnidipta Ayachi, Aicha Gharbi Mushtaq, Aisha Shaqra, Ala M. Toh, Alan Kie Leong Smrcka, Alan V. Ciccia, Alberto de Oliveira, Aldo Sena Sverzhinsky, Aleksandr de Sousa, Alessandra Mara Agoulnik, Alexander I. Kushnir, Alexander Freiberg, Alexander N. Statsyuk, Alexander V. Gingras, Alexandre R. Degterev, Alexei Tomilov, Alexey Vrielink, Alice Garaeva, Alisa A. Bryant-Friedrich, Amanda Caflisch, Amedeo Patel, Amit K. Rangarajan, Amith Vikram Matheeussen, An Battistoni, Andrea Caporali, Andrea Chini, Andrea Ilari, Andrea Mattevi, Andrea Foote, Andrea Talbot Trabocchi, Andrea Stahl, Andreas Herr, Andrew B. Berti, Andrew Freywald, Andrew Reidenbach, Andrew G. Lam, Andrew Cuddihy, Andrew R. White, Andrew Taglialatela, Angelo School of Biological Sciences Medicine, Health and Life Sciences High throughput screening AI High throughput screening (HTS) is routinely used to identify bioactive small molecules. This requires physical compounds, which limits coverage of accessible chemical space. Computational approaches combined with vast on-demand chemical libraries can access far greater chemical space, provided that the predictive accuracy is sufficient to identify useful molecules. Through the largest and most diverse virtual HTS campaign reported to date, comprising 318 individual projects, we demonstrate that our AtomNet® convolutional neural network successfully finds novel hits across every major therapeutic area and protein class. We address historical limitations of computational screening by demonstrating success for target proteins without known binders, high-quality X-ray crystal structures, or manual cherry-picking of compounds. We show that the molecules selected by the AtomNet® model are novel drug-like scaffolds rather than minor modifications to known bioactive compounds. Our empirical results suggest that computational methods can substantially replace HTS as the first step of small-molecule drug discovery. Published version 2024-08-12T01:58:44Z 2024-08-12T01:58:44Z 2024 Journal Article Wallach, I., Bernard, D., Nguyen, K., Ho, G., Morrison, A., Stecula, A., Rosnik, A., O’Sullivan, A. M., Davtyan, A., Samudio, B., Thomas, B., Worley, B., Butler, B., Laggner, C., Thayer, D., Moharreri, E., Friedland, G., Truong, H., van den Bedem, H., ...Taglialatela, A. (2024). AI is a viable alternative to high throughput screening: a 318-target study. Scientific Reports, 14(1), 7526-. https://dx.doi.org/10.1038/s41598-024-54655-z 2045-2322 https://hdl.handle.net/10356/179577 10.1038/s41598-024-54655-z 38565852 2-s2.0-85191821387 1 14 7526 en Scientific Reports © 2024 The Author(s). Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. application/pdf |
spellingShingle | Medicine, Health and Life Sciences High throughput screening AI Wallach, Izhar Bernard, Denzil Nguyen, Kong Ho, Gregory Morrison, Adrian Stecula, Adrian Rosnik, Andreana O’Sullivan, Ann Marie Davtyan, Aram Samudio, Ben Thomas, Bill Worley, Brad Butler, Brittany Laggner, Christian Thayer, Desiree Moharreri, Ehsan Friedland, Greg Truong, Ha van den Bedem, Henry Ng, Ho Leung Stafford, Kate Sarangapani, Krishna Giesler, Kyle Ngo, Lien Mysinger, Michael Ahmed, Mostafa Anthis, Nicholas J. Henriksen, Niel Gniewek, Pawel Eckert, Sam de Oliveira, Saulo Suterwala, Shabbir PrasadPrasad, Srimukh Veccham Krishna Shek, Stefani Contreras, Stephanie Hare, Stephanie Palazzo, Teresa O’Brien, Terrence E. Van Grack, Tessa Williams, Tiffany Chern, Ting-Rong Kenyon, Victor Lee, Andreia H. Cann, Andrew B. Bergman, Bastiaan Anderson, Brandon M. Cox, Bryan D. Warrington, Jeffrey M. Sorenson, Jon M. Goldenberg, Joshua M. Young, Matthew A. DeHaan, Nicholas Pemberton, Ryan P. Schroedl, Stefan Abramyan, Tigran M. Gupta, Tushita Mysore, Venkatesh Presser, Adam G. Ferrando, Adolfo A. Andricopulo, Adriano D. Ghosh, Agnidipta Ayachi, Aicha Gharbi Mushtaq, Aisha Shaqra, Ala M. Toh, Alan Kie Leong Smrcka, Alan V. Ciccia, Alberto de Oliveira, Aldo Sena Sverzhinsky, Aleksandr de Sousa, Alessandra Mara Agoulnik, Alexander I. Kushnir, Alexander Freiberg, Alexander N. Statsyuk, Alexander V. Gingras, Alexandre R. Degterev, Alexei Tomilov, Alexey Vrielink, Alice Garaeva, Alisa A. Bryant-Friedrich, Amanda Caflisch, Amedeo Patel, Amit K. Rangarajan, Amith Vikram Matheeussen, An Battistoni, Andrea Caporali, Andrea Chini, Andrea Ilari, Andrea Mattevi, Andrea Foote, Andrea Talbot Trabocchi, Andrea Stahl, Andreas Herr, Andrew B. Berti, Andrew Freywald, Andrew Reidenbach, Andrew G. Lam, Andrew Cuddihy, Andrew R. White, Andrew Taglialatela, Angelo AI is a viable alternative to high throughput screening: a 318-target study |
title | AI is a viable alternative to high throughput screening: a 318-target study |
title_full | AI is a viable alternative to high throughput screening: a 318-target study |
title_fullStr | AI is a viable alternative to high throughput screening: a 318-target study |
title_full_unstemmed | AI is a viable alternative to high throughput screening: a 318-target study |
title_short | AI is a viable alternative to high throughput screening: a 318-target study |
title_sort | ai is a viable alternative to high throughput screening a 318 target study |
topic | Medicine, Health and Life Sciences High throughput screening AI |
url | https://hdl.handle.net/10356/179577 |
work_keys_str_mv | AT wallachizhar aiisaviablealternativetohighthroughputscreeninga318targetstudy AT bernarddenzil aiisaviablealternativetohighthroughputscreeninga318targetstudy AT nguyenkong aiisaviablealternativetohighthroughputscreeninga318targetstudy AT hogregory aiisaviablealternativetohighthroughputscreeninga318targetstudy AT morrisonadrian aiisaviablealternativetohighthroughputscreeninga318targetstudy AT steculaadrian aiisaviablealternativetohighthroughputscreeninga318targetstudy AT rosnikandreana aiisaviablealternativetohighthroughputscreeninga318targetstudy AT osullivanannmarie aiisaviablealternativetohighthroughputscreeninga318targetstudy AT davtyanaram aiisaviablealternativetohighthroughputscreeninga318targetstudy AT samudioben aiisaviablealternativetohighthroughputscreeninga318targetstudy AT thomasbill aiisaviablealternativetohighthroughputscreeninga318targetstudy AT worleybrad aiisaviablealternativetohighthroughputscreeninga318targetstudy AT butlerbrittany aiisaviablealternativetohighthroughputscreeninga318targetstudy AT laggnerchristian aiisaviablealternativetohighthroughputscreeninga318targetstudy AT thayerdesiree aiisaviablealternativetohighthroughputscreeninga318targetstudy AT moharreriehsan aiisaviablealternativetohighthroughputscreeninga318targetstudy AT friedlandgreg aiisaviablealternativetohighthroughputscreeninga318targetstudy AT truongha aiisaviablealternativetohighthroughputscreeninga318targetstudy AT vandenbedemhenry aiisaviablealternativetohighthroughputscreeninga318targetstudy AT ngholeung aiisaviablealternativetohighthroughputscreeninga318targetstudy AT staffordkate aiisaviablealternativetohighthroughputscreeninga318targetstudy AT sarangapanikrishna aiisaviablealternativetohighthroughputscreeninga318targetstudy AT gieslerkyle aiisaviablealternativetohighthroughputscreeninga318targetstudy AT ngolien aiisaviablealternativetohighthroughputscreeninga318targetstudy AT mysingermichael aiisaviablealternativetohighthroughputscreeninga318targetstudy AT ahmedmostafa aiisaviablealternativetohighthroughputscreeninga318targetstudy AT anthisnicholasj aiisaviablealternativetohighthroughputscreeninga318targetstudy AT henriksenniel aiisaviablealternativetohighthroughputscreeninga318targetstudy AT gniewekpawel aiisaviablealternativetohighthroughputscreeninga318targetstudy AT eckertsam aiisaviablealternativetohighthroughputscreeninga318targetstudy AT deoliveirasaulo aiisaviablealternativetohighthroughputscreeninga318targetstudy AT suterwalashabbir aiisaviablealternativetohighthroughputscreeninga318targetstudy AT prasadprasadsrimukhvecchamkrishna aiisaviablealternativetohighthroughputscreeninga318targetstudy AT shekstefani aiisaviablealternativetohighthroughputscreeninga318targetstudy AT contrerasstephanie aiisaviablealternativetohighthroughputscreeninga318targetstudy AT harestephanie aiisaviablealternativetohighthroughputscreeninga318targetstudy AT palazzoteresa aiisaviablealternativetohighthroughputscreeninga318targetstudy AT obrienterrencee aiisaviablealternativetohighthroughputscreeninga318targetstudy AT vangracktessa aiisaviablealternativetohighthroughputscreeninga318targetstudy AT williamstiffany aiisaviablealternativetohighthroughputscreeninga318targetstudy AT cherntingrong aiisaviablealternativetohighthroughputscreeninga318targetstudy AT kenyonvictor aiisaviablealternativetohighthroughputscreeninga318targetstudy AT leeandreiah aiisaviablealternativetohighthroughputscreeninga318targetstudy AT cannandrewb aiisaviablealternativetohighthroughputscreeninga318targetstudy AT bergmanbastiaan aiisaviablealternativetohighthroughputscreeninga318targetstudy AT andersonbrandonm aiisaviablealternativetohighthroughputscreeninga318targetstudy AT coxbryand aiisaviablealternativetohighthroughputscreeninga318targetstudy AT warringtonjeffreym aiisaviablealternativetohighthroughputscreeninga318targetstudy AT sorensonjonm aiisaviablealternativetohighthroughputscreeninga318targetstudy AT goldenbergjoshuam aiisaviablealternativetohighthroughputscreeninga318targetstudy AT youngmatthewa aiisaviablealternativetohighthroughputscreeninga318targetstudy AT dehaannicholas aiisaviablealternativetohighthroughputscreeninga318targetstudy AT pembertonryanp aiisaviablealternativetohighthroughputscreeninga318targetstudy AT schroedlstefan aiisaviablealternativetohighthroughputscreeninga318targetstudy AT abramyantigranm aiisaviablealternativetohighthroughputscreeninga318targetstudy AT guptatushita aiisaviablealternativetohighthroughputscreeninga318targetstudy AT mysorevenkatesh aiisaviablealternativetohighthroughputscreeninga318targetstudy AT presseradamg aiisaviablealternativetohighthroughputscreeninga318targetstudy AT ferrandoadolfoa aiisaviablealternativetohighthroughputscreeninga318targetstudy AT andricopuloadrianod aiisaviablealternativetohighthroughputscreeninga318targetstudy AT ghoshagnidipta aiisaviablealternativetohighthroughputscreeninga318targetstudy AT ayachiaichagharbi aiisaviablealternativetohighthroughputscreeninga318targetstudy AT mushtaqaisha aiisaviablealternativetohighthroughputscreeninga318targetstudy AT shaqraalam aiisaviablealternativetohighthroughputscreeninga318targetstudy AT tohalankieleong aiisaviablealternativetohighthroughputscreeninga318targetstudy AT smrckaalanv aiisaviablealternativetohighthroughputscreeninga318targetstudy AT cicciaalberto aiisaviablealternativetohighthroughputscreeninga318targetstudy AT deoliveiraaldosena aiisaviablealternativetohighthroughputscreeninga318targetstudy AT sverzhinskyaleksandr aiisaviablealternativetohighthroughputscreeninga318targetstudy AT desousaalessandramara aiisaviablealternativetohighthroughputscreeninga318targetstudy AT agoulnikalexanderi aiisaviablealternativetohighthroughputscreeninga318targetstudy AT kushniralexander aiisaviablealternativetohighthroughputscreeninga318targetstudy AT freibergalexandern aiisaviablealternativetohighthroughputscreeninga318targetstudy AT statsyukalexanderv aiisaviablealternativetohighthroughputscreeninga318targetstudy AT gingrasalexandrer aiisaviablealternativetohighthroughputscreeninga318targetstudy AT degterevalexei aiisaviablealternativetohighthroughputscreeninga318targetstudy AT tomilovalexey aiisaviablealternativetohighthroughputscreeninga318targetstudy AT vrielinkalice aiisaviablealternativetohighthroughputscreeninga318targetstudy AT garaevaalisaa aiisaviablealternativetohighthroughputscreeninga318targetstudy AT bryantfriedrichamanda aiisaviablealternativetohighthroughputscreeninga318targetstudy AT caflischamedeo aiisaviablealternativetohighthroughputscreeninga318targetstudy AT patelamitk aiisaviablealternativetohighthroughputscreeninga318targetstudy AT rangarajanamithvikram aiisaviablealternativetohighthroughputscreeninga318targetstudy AT matheeussenan aiisaviablealternativetohighthroughputscreeninga318targetstudy AT battistoniandrea aiisaviablealternativetohighthroughputscreeninga318targetstudy AT caporaliandrea aiisaviablealternativetohighthroughputscreeninga318targetstudy AT chiniandrea aiisaviablealternativetohighthroughputscreeninga318targetstudy AT ilariandrea aiisaviablealternativetohighthroughputscreeninga318targetstudy AT matteviandrea aiisaviablealternativetohighthroughputscreeninga318targetstudy AT footeandreatalbot aiisaviablealternativetohighthroughputscreeninga318targetstudy AT trabocchiandrea aiisaviablealternativetohighthroughputscreeninga318targetstudy AT stahlandreas aiisaviablealternativetohighthroughputscreeninga318targetstudy AT herrandrewb aiisaviablealternativetohighthroughputscreeninga318targetstudy AT bertiandrew aiisaviablealternativetohighthroughputscreeninga318targetstudy AT freywaldandrew aiisaviablealternativetohighthroughputscreeninga318targetstudy AT reidenbachandrewg aiisaviablealternativetohighthroughputscreeninga318targetstudy AT lamandrew aiisaviablealternativetohighthroughputscreeninga318targetstudy AT cuddihyandrewr aiisaviablealternativetohighthroughputscreeninga318targetstudy AT whiteandrew aiisaviablealternativetohighthroughputscreeninga318targetstudy AT taglialatelaangelo aiisaviablealternativetohighthroughputscreeninga318targetstudy |